572 filings
Page 4 of 29
ARS
eim1ljdxvbwanqlybgq
28 Apr 23
Annual report to shareholders
8:21am
8-K
6o3baoqihv
26 Apr 23
Other Events
4:59pm
UPLOAD
4sq2evcfighqybk8usk7
19 Apr 23
Letter from SEC
12:00am
424B5
nhtnxsc
11 Apr 23
Prospectus supplement for primary offering
9:02pm
8-K
w0lnagrg0wdza 3x7u
10 Apr 23
Agile Therapeutics Announces 1-FOR-50 Reverse Stock Split
5:16pm
8-K
0ly6qyozja2wmf sbb
30 Mar 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:35pm
8-K
e05ey59q a1g
22 Mar 23
Agile Therapeutics Reports Fourth Quarter & Full Year 2022 Financial Results and Provides Corporate Update
4:15pm
8-K
0g7oph
14 Mar 23
Departure of Directors or Certain Officers
4:29pm
8-K
qddrmsg6m164w3ihw3
27 Feb 23
Agile Therapeutics Granted 180-DAY Extension by Nasdaq to Meet the Minimum Bid Price Requirement
8:30am
SC 13G/A
9li 7mjn99ys
14 Feb 23
AGILE THERAPEUTICS / PERCEPTIVE ADVISORS ownership change
2:31pm
SC 13G/A
kfw5db4 hjqpqoxs3
13 Feb 23
AGILE THERAPEUTICS / Lind Global Fund II ownership change
4:33pm
SC 13G/A
h2qjp 87pp4
8 Feb 23
AGILE THERAPEUTICS / INTRACOASTAL CAPITAL ownership change
6:06am
8-A12G
zyks75tb k40
26 Jan 23
Registration of securities
5:20pm
8-K
wqvqtp1
26 Jan 23
Agile Therapeutics Announces Distribution of Series C Preferred Stock to Its Holders of Common Stock
5:11pm
8-K
k5i8f2ltml 4u
9 Jan 23
Results of Operations and Financial Condition
4:30pm